cellvie
cellvie's Overview
Cellvie is a biopharmaceutical company dedicated to pioneering mitochondria-based therapies to address unmet medical needs. Their primary focus is on Therapeutic Mitochondria Transplantation (TMT) and other innovative approaches to augment mitochondrial function. By targeting cellular energy deficits, Cellvie aims to treat conditions such as age-related decline, ischemia-reperfusion injuries (often seen in heart attacks, strokes, and organ transplantation), and other diseases linked to mitochondrial dysfunction. The company's science revolves around isolating healthy, potent mitochondria and delivering them to damaged cells to restore bioenergetic capacity, improve cellular function, and ultimately enhance patient outcomes. Cellvie is advancing a pipeline of therapies with the potential to revolutionize treatment for a range of debilitating conditions.
Where is cellvie's Headquarters?
HQ Function
Primary research and development, corporate administration, strategic operations, and management of global collaborations.
Notable Features:
Located within the Bio-Technopark Schlieren-Zürich, offering access to state-of-the-art laboratory facilities, shared core services, and a vibrant ecosystem of life science companies and research institutions.
Work Culture:
A dynamic, innovative, and science-driven environment that fosters collaboration, precision, and a commitment to translational research. The culture encourages intellectual curiosity and a fast-paced approach to tackling complex biological challenges.
HQ Significance:
Strategically situated in a leading European life sciences hub, providing access to world-class research talent, academic collaborations, and a supportive infrastructure for biotech innovation and growth.
Values Reflected in HQ: The headquarters' location and facilities reflect Cellvie's commitment to cutting-edge science, innovation, collaboration, and the efficient development of transformative therapies.
Location:
Cellvie operates with a global outlook, anchored by its headquarters in Switzerland and a key office in Cambridge, MA, USA. The company actively engages in international research collaborations with academic institutions and industry partners to advance its mitochondrial therapy platform. While its therapies are currently in development, Cellvie's focus on conditions with significant worldwide impact, such as age-related diseases and ischemia-reperfusion injuries, underscores its commitment to addressing global health challenges.
Street Address:
Wagistrasse 27
City:
Schlieren
State/Province:
Zurich
Country:
Switzerland
cellvie's Global Presence
Cambridge, MA, USA
Address: LabCentral, 700 Main Street, Cambridge, MA 02139, USA
To establish a strong presence in a leading global biotech cluster, facilitating access to cutting-edge research, strategic partnerships, and supporting future clinical development and commercialization efforts in North America.
Buying Intent Signals for cellvie
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of cellvie
As of April 2025, cellvie' leadership includes:
Investors of cellvie
cellvie has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Cellvie's core executive team has remained consistent over the past 12 months, focused on strategic growth and pipeline development following their Series A financing. No major executive appointments or departures have been publicly announced during this period.
Technology (Tech Stack) used by cellvie
Discover the tools cellvie uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
cellvie Email Formats and Examples
Common email formats for Cellvie likely follow standard professional patterns. While not publicly confirmed, formats such as [first].[last]@cellvie.com or [first_initial][last]@cellvie.com are frequently used in the biotech industry.
[first].[last]@cellvie.com
Format
alexander.schueller@cellvie.com
Example
85%
Success rate
News and media
Business Wire • November 14, 2023
Cellvie Secures $26.5 Million Series A Financing to Advance Mitochondrial Augmentation Platform
Cellvie announced the successful closing of a $26.5 million Series A financing round. The funding was co-led by Taiho Ventures and XGEN Venture, with participation from Roche Venture Fund, Kizoo Technology Capital, Occident, and Healthequity. These funds will be used to advance Cellvie's pipeline of mitochondrial augmentation therapies and expand its research capabilities....more
Cellvie Website News • January 26, 2021
Cellvie Inc. Raises Oversubscribed Seed Round of CHF 5 Million
Cellvie Inc. announced the closing of an oversubscribed seed financing round of CHF 5 million (~USD 5.5M) led by Kizoo Technology Capital. The financing enables the expansion of R&D activities for its platform technology, Therapeutic Mitochondria Transplantation, and the continued development of its lead indication in Ischemia Reperfusion Injury....more
European Biotechnology • October 10, 2023
Cellvie: Mitochondrial transplant protects hearts
Cellvie's research, published in a leading scientific journal, demonstrated that transplantation of viable mitochondria can protect heart tissue from ischemia-reperfusion injury. This study highlights the therapeutic potential of their approach in cardiac conditions....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including cellvie, are just a search away.